Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 10 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 0,5 mg Fingolimod | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬1. 0,5 mg Fingolimod
| [1] S1PR1 S1PR1 💬1. 0,5 mg Fingolimod
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [1] 13 13 💬1. 0,5 mg Fingolimod
| ||||||||||||||||||||||||||
| 2 | FINGOLIMOD | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬2. FINGOLIMOD
| [1] S1PR1 S1PR1 💬2. FINGOLIMOD
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [3] 13 13, 14, 156 💬
| ||||||||||||||||||||||||||
| 3 | Fingolimod (FTY720) | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬3. Fingolimod (FTY720)
| [1] S1PR1 S1PR1 💬3. Fingolimod (FTY720)
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [2] 13 13, 156 💬
| ||||||||||||||||||||||||||
| 4 | Fingolimod 0.5 mg | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬4. Fingolimod 0.5 mg
| [1] S1PR1 S1PR1 💬4. Fingolimod 0.5 mg
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [1] 13 13 💬4. Fingolimod 0.5 mg
| ||||||||||||||||||||||||||
| 5 | Fingolimod 0.5mg | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬5. Fingolimod 0.5mg
| [1] S1PR1 S1PR1 💬5. Fingolimod 0.5mg
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [1] 13 13 💬5. Fingolimod 0.5mg
| ||||||||||||||||||||||||||
| 6 | Fingolimod 1.25 mg | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬6. Fingolimod 1.25 mg
| [1] S1PR1 S1PR1 💬6. Fingolimod 1.25 mg
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [1] 13 13 💬6. Fingolimod 1.25 mg
| ||||||||||||||||||||||||||
| 7 | FINGOLIMOD HYDROCHLORIDE | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬7. FINGOLIMOD HYDROCHLORIDE
| [1] S1PR1 S1PR1 💬7. FINGOLIMOD HYDROCHLORIDE
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [2] 13 13, 14 💬
| ||||||||||||||||||||||||||
| 8 | Fingolimodi | - | - | - | - | [1] 13 13 💬8. Fingolimodi
| ||||||||||||||||||||||||||
| 9 | Hidrocloruro de fingolimod | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬9. Hidrocloruro de fingolimod
| [1] S1PR1 S1PR1 💬9. Hidrocloruro de fingolimod
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [2] 13 13, 14 💬
| ||||||||||||||||||||||||||
| 10 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolim ... | [12] Acetate Acetate,Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab, Ocrelizumab, Ofatumumab, Ponesimod, Rituximab, Teriflunomide [12] Acetate, Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab, Ocrelizumab, ... | [10] Cladribine
Cladribine
,Alemtuzumab , Rituximab , Dimethyl fumarate , Ocrelizumab , Natalizumab , Ofatumumab , Fingolimod , Teriflunomide , Ponesimod 💬 [10] Cladribine , Alemtuzumab , Rituximab , Dimethyl fumarate , Ocrelizumab , Natalizuma ... 10. Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
| [7] CD52 CD52,DHODH, ITGA4, KEAP1, MS4A1, RRM1, S1PR1 💬 10. Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab | [30] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬 [30] Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molec ... | [1] 13 13 💬10. Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
|